NASDAQ · Biotechnology

SEER (SEER) Stock

$2.08 +5.40% NASDAQ: SEER Healthcare

Valuation

MetricValue
Price$2.08
Market Cap$114.16M
P/E Ratio-1.77
P/B Ratio0.38
P/S Ratio6.36
EPS (TTM)$-1.28
52-Week High$2.41
52-Week Low$1.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.52%
ROA-15.04%
ROCE-30.12%
Gross Margin48.26%
Operating Margin-4.96%
Net Margin-4.69%
Debt/Equity0.10
Current Ratio12.63

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$15.0M$15.0M$14.0M$16.0M
Operating Profit$-72.0M$-98.0M$-105.0M$-100.0M$-78.0M
Net Profit$-71.0M$-93.0M$-86.0M$-87.0M$-74.0M
EPS$-1.13$-1.42$-1.35$-1.39$-1.28
Op Margin-1121.3%-667.6%-691.2%-717.7%-486.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$539.0M$488.0M$436.0M$367.0M$296.0M
Total Liabilities$36.0M$41.0M$39.0M$39.0M$37.0M
Cash$233.0M$53.0M$32.0M$41.0M$47.0M
Borrowings$23.0M$30.0M$28.0M$26.0M$24.0M

Latest News

Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc. Business Wire · Jul 22, 2026 Seer Urges Stockholders to Vote “FOR” Seer’s Highly Qualified Director Nominees on the BLUE Proxy Card TODAY GlobeNewswire · Jul 20, 2026 Special Committee of Seer’s Board of Directors Unanimously Rejects Unsolicited Acquisition Proposal from Omid Farokhzad, M.D. GlobeNewswire · Jul 20, 2026 Radoff-JEC Group Announces ISS’ Support of its Case for Change at Seer, Inc. Business Wire · Jul 17, 2026 Seer Board of Directors Issues Letter to Shareholders Setting the Record Straight GlobeNewswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-46.0M$-61.0M$-59.0M$-46.0M$-44.0M
Investing Cash Flow$-178.0M$-133.0M$31.0M$62.0M$60.0M
Financing Cash Flow$14.0M$4.0M$0$-11.0M$-11.0M
Net Cash Flow$-101.0M$-180.0M$-21.0M$8.0M$7.0M
Free Cash Flow$-53.0M$-71.0M$-66.0M$-50.0M$-46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-11.79
EV / EBITDA0.72
FCF Yield-52.14%
Quick Ratio16.94
Interest Coverage—
Return 1Y1.41%
Return 3Y-54.81%
Return 5Y-92.19%

Ownership

Insiders Held14.46%
Institutions Held51.27%
Institutions Float Held59.94%
Institutional HolderSharesReport Date
Softbank Group Corporation5,135,3832026-03-31
Siren, L.L.C.2,458,6732026-03-31
Acadian Asset Management. LLC2,074,7092026-03-31
Vanguard Capital Management LLC1,958,9962026-03-31
Blackrock Inc.1,821,6042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANEBAnebulo Pharmaceuticals, Inc. $0.34 +0.00% -1.73 $13.72M 0.00%
ANTX $4.93 +0.20% -4.76 $177.56M 0.00%
CCCC $3.52 -0.85% -2.54 $389.20M 0.00%
CGEM $17.21 -1.49% -3.76 $1.06B 0.00%
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%

About SEER

SEER is led by CEO Omid C. Farokhzad, employs 134 people, headquartered in US, publicly traded since 2020.

SEER stock trades at $2.08 with a market capitalization of $114.16M. The stock is valued at a price-to-earnings (P/E) ratio of -1.77, price-to-book of 0.38, price-to-sales of 6.36. Over the past 52 weeks the stock has ranged between $1.58 and $2.41, and currently trades 13.7% below its 52-week high.

On profitability, SEER generates a return on equity (ROE) of -25.52%, return on capital employed of -30.12%, an operating margin of -4.96%, a net profit margin of -4.69%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides